Imatinib
Imatinib oral solid — targeted therapy for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). WHO-GMP certified, export-ready.
Imatinib
As per manufacturer specification
Mehadia Tradelinks
Pricing and availability are confirmed by our team after checking the product, quantity, destination rules, and required documentation.
Bulk quotes, documentation, and shipping options are handled manually after prescription, buyer, and destination checks where applicable.
Imatinib (Imatib 100/400) contains Imatinib, a targeted therapy agent. This product works as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity. It is primarily indicated for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Manufactured by Mehadia Tradelinks in compliance with WHO-GMP standards, each batch undergoes rigorous quality testing including HPLC assay, dissolution testing, and stability studies. Available for pharmaceutical export with Certificate of Analysis and full regulatory documentation.
5 Fluorouracil
500mg
Mehadia Tradelinks
Alrubicin Epirubicin
10mg
Vea Impex
Betaxel
30 mg
Vea Impex
Bortezomib
2mg
Mehadia Tradelinks